Document is current
Any future updates will be listed below
-
Authors
Mizuochi, Tatsuki https://orcid.org/0000-0002-2943-7068
Iwama, Itaru
Inui, Ayano
Ito, Yoshinori
Takaki, Yugo
Mushiake, Sotaro
Tokuhara, Daisuke
Ishige, Takashi
Ito, Koichi
Murakami, Jun
Hishiki, Haruka
Mikami, Hitoshi
Bessho, Kazuhiko
Kato, Ken
Yasuda, Ryosuke
Yamashita, Yushiro
Tanaka, Yasuhito
Tajiri, Hitoshi
-
Funding
Funding for this research was provided by:
Research Program on Hepatitis from the Japanese Agency for Medical Research and Development, AMED (22fk0210068h0003, 22fk0210068h0003, 22fk0210103)
- License Information
-
More Information
Article History
Received: 17 October 2022
Accepted: 5 February 2023
First Online: 15 February 2023
Declarations
:
: Tatsuki Mizuochi reports personal fees from AbbVie GK. Yasuhito Tanaka reports personal fees from Gilead Sciences Inc., Fujirebio Inc., and AbbVie GK; research grants from Gilead Sciences, Inc., Fujirebio Inc., AbbVie GK, and Board of Trustees of the Leland Stanford Junior University.
: This study protocol complied with the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Kurume University and its counterparts at other participating centers.
